Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

NCT: NCT07052292 · COMPLETED

NCT IDNCT07052292
StatusCOMPLETED
Start Date2025-07-01
Completion2026-01-09

Brief Summary

This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12 weeks.

Frequently Asked Questions

What is User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes?

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes is a clinical trial registered under NCT07052292. Current status: COMPLETED.

What is the status of NCT07052292?

The current status of NCT07052292 (User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes) is: COMPLETED.

When did User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes start?

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes started on 2025-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑